Asian currencies rose after a European Central Bank official suggested the region should stop trying to curb their appreciation. \nThe bank's chief economist Otmar Issing urged Asian governments to let their currencies strengthen to ease pressure on the euro, which rose almost twice as much as the South Korean won in the past three years. \n"Asia is not doing its fair share," as Europe takes the brunt of the US dollar's decline, said Robert Rennie, a currency strategist at Westpac Banking Corp. \nIssing's comments on Tuesday may have prompted some investors "to unwind" some of their dollar purchases because Asian currencies haven't risen as much, Sydney-based Rennie said. \nThe New Taiwan dollar yesterday rose 0.3 percent to NT$32.028 against its US counterpart, Taipei Forex Inc data show. The yen traded at ?103.38, near a one-week high of ?103.12 reached on Tuesday in New York. \nThe won climbed 0.3 percent to 1,042.20 against the US dollar as of 4pm in Seoul, according to Seoul Money Brokerage Services Ltd. \nThe won's 27 percent gain in the past three years lagged the euro's 52 percent climb versus the US dollar. The yen rose 28 percent and the NT dollar appreciated 10 percent in the same period. \nThe euro's advance has "gone too far," Issing said at a conference in Zurich. "The key to this problem lies with Asia and especially in the hands of China."
Gogoro Inc (睿能創意) yesterday launched its first electric bicycle, the Gogoro Eeyo 1, in Taiwan, after unveiling the bike in New York in late May and in France on Tuesday. The company said it would also introduce the series in other European countries such as Germany and the Netherlands. The “Eeyo project” is the fourth of Gogoro’s eight projects that concentrate on smart transportation, which includes Gogoro’s electric scooter, battery swap system and electric scooter sharing service, company founder and chief executive officer Horace Luke (陸學森) told a media briefing in Taipei. “There are various types of city commuters. We will not
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price
NOT A PANACEA: Offering 5G services would not solve the problem of declining telecom incomes, chairman Sheih Chi-mau said, expecting a flat 5G telecom revenue Chunghwa Telecom Co (中華電信) yesterday became the nation’s first telecom to debut its 5G services, offering tiered tariffs that include a threshold of NT$599 and flat rates, as it aims to switch half of its subscribers to the 5G network within three years. Subscribers would have unlimited data transmission for monthly fees starting at NT$1,399 — the same flat rate as when the company launched its 4G service in 2014 — and they can subscribe to the highest-rate plan for NT$2,699 per month for faster data transmission speeds and larger bandwidth, the company said. Data transmission speeds would be within the range
ROW: A probe would determine if the rights of shareholders who were not allowed to vote yesterday had been violated, while the stock exchange also wants answers The election of board directors yesterday at Tatung Co (大同) sparked controversy after the company blocked some institutional and individual shareholders from participating in the general shareholders’ meeting, prompting the Financial Supervisory Commission (FSC) to announce that the vote would be investigated. Lin Kuo Wen-yen (林郭文艷) was re-elected as chairwoman of the household-appliance maker’s nine-member board, but prior to the vote she announced that several shareholders would not have voting rights. They were being denied a vote because they had contravened the Business Mergers and Acquisitions Act (企業併購法), and the Act Governing Relations Between the People of the Taiwan Area and